C. diff assay receives FDA clearance
by Press Release from Outbreak News Today on (#398VT)
GenePOC Inc announced today that its Clostridium difficile assay, GenePOCa CDiff, for use on the revogenea instrument, received clearance from the US Food and Drug Administration (FDA). The GenePOC CDiff test targets the toxin B gene of toxigenic C. difficile strains in unformed stool specimens obtained from patients suspected of having C. difficile infection (CDI). ["]
The post C. diff assay receives FDA clearance appeared first on Outbreak News Today.